Loading...
Pfizer Inc. Delivers Resilient Q3 and 9M 2025 Performance with Strong EPS Outperformance, Cost Discipline and Strategic Repositioning
WA
Wane_Investment_House
Not Invested
Community Contributor
Published
04 Jan 26
Views
284
04 Jan
US$26.18
Wane_Investment_House's Fair Value
US$25.50
2.7% overvalued intrinsic discount1Y
11.5%7D
1.1%1Y
11.5%7D
1.1%You can edit this narrative until Jan 5 1:00 PM. Then, changes will post as Updates.
Author's Valuation
US$25.52.7% overvalued intrinsic discount
Wane_Investment_House's Fair Value